[HTML] frontiersin.org

[HTML][HTML] Short-term effectiveness of baricitinib in children with refractory and/or severe juvenile dermatomyositis

Z Wang, Q Zheng, W Xuan, X Xu, M Lu, J Wu… - Frontiers in …, 2022 - frontiersin.org
Objective To determine the short-term effectiveness safety of baricitinib in children with
refractory and/or severe juvenile dermatomyositis (rsJDM) in a real-world setting. Methods …
被引用次数：8 相关文章
[HTML] nih.gov

[HTML][HTML] Short-term effectiveness of baricitinib in children with refractory and/or severe juvenile dermatomyositis

Z Wang, Q Zheng, W Xuan, X Xu, M Lu, J Wu… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Objective To determine the short-term effectiveness safety of baricitinib in children with
refractory and/or severe juvenile dermatomyositis (rsJDM) in a real-world setting. Methods …

Short-term effectiveness of baricitinib in children with refractory and/or severe juvenile dermatomyositis

Z Wang, Q Zheng, W Xuan, X Xu, M Lu… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective To determine the short-term effectiveness safety of baricitinib in children with
refractory and/or severe juvenile dermatomyositis (rsJDM) in a real-world setting. Methods …

Short-term effectiveness of baricitinib in children with refractory and/or severe juvenile dermatomyositis.

Z Wang, Q Zheng, W Xuan, X Xu, M Lu, J Wu… - Frontiers in …, 2022 - europepmc.org
Objective To determine the short-term effectiveness safety of baricitinib in children with
refractory and/or severe juvenile dermatomyositis (rsJDM) in a real-world setting. Methods …